A large meta-analysis assesses the evidence of a link between shift work and a heightened risk for type 2 diabetes. The analysis finds that men are at particular risk.
A study in rats reveals that tamoxifen - a drug typically used to treat breast cancer that has spread - is less effective when subjects are exposed to dim light at night.
DeVilbiss Healthcare Named Finalist for the 2014 Pennsylvania Governor’s Impact Awards for Its Impact on Exports
SOMERSET, PA – April 23, 2014 – DeVilbiss Healthcare was recently named one of five finalists for the 2014 Pennsylvania Governor’s Impact Awards in the Export Impact category for the Southern Alleghenies Region. This is the second consecutive year DeVilbiss has been named a finalist. The awards program was created to honor and celebrate companies across the state that have had substantial impact on growing the economy and contributing to job growth and retention.
SOMERSET, PA – April 10, 2014 – DeVilbiss Healthcare was recently awarded a patent* for its innovative SmartCode® Remote Therapy Monitoring system. The development of SmartCode technology revolutionized the way in which patients can remotely report CPAP therapy usage and efficacy data to the health provider. With this patent, DeVilbiss is now protected from other imitation codes on the market.
Receive E-Mail Updates